Open-label, Randomized, Controlled, Phase 3 Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) with Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only Subjects

Type of Cancer
Neuro-Oncology

Sponsor
Diffusion Pharma

Protocol Number
100-206

To Learn More Call
(201)-510-0950